Niagen Bioscience Q3 EPS $(0.01) Misses $0.02 Estimate, Sales $27.192M Miss $32.062M Estimate
Benzinga Newsdesk 3 days ago
NewsEarningsEarnings Misses
Niagen Bioscience (NASDAQ:NAGE) reported quarterly losses of $(0.01) per share which missed the analyst consensus estimate of $0.02 by 150 percent. This is a 120 percent decrease over earnings of $0.05 per share from
Niagen Bioscience (NASDAQ:NAGE) reported quarterly losses of $(0.01) per share which missed the analyst consensus estimate of $0.02 by 150 percent. This is a 120 percent decrease over earnings of $0.05 per share from the same period last year. The company reported quarterly sales of $27.192 million which missed the analyst consensus estimate of $32.062 million by 15.19 percent. This is a 19.99 percent decrease over sales of $33.986 million the same period last year.